Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Type I interferon in organ-targeted autoimmune and inflammatory diseases.

Crow MK.

Arthritis Res Ther. 2010;12 Suppl 1:S5. doi: 10.1186/ar2886. Epub 2010 Aug 25. Review.

2.

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.

de Jong TD, Vosslamber S, Mantel E, de Ridder S, Wesseling JG, van der Pouw Kraan TC, Leurs C, Hegen H, Deisenhammer F, Killestein J, Lundberg IE, Vencovsky J, Nurmohamed MT, van Schaardenburg D, Bultink IE, Voskuyl AE, Pegtel DM, van der Laken CJ, Bijlsma JW, Verweij CL.

Arthritis Res Ther. 2016 Feb 17;18:49. doi: 10.1186/s13075-016-0946-9.

3.

Modulation of toll-like receptor function has therapeutic potential in autoimmune disease.

Clanchy FI, Sacre SM.

Expert Opin Biol Ther. 2010 Dec;10(12):1703-16. doi: 10.1517/14712598.2010.534080. Epub 2010 Nov 2. Review.

PMID:
21039312
4.

The modulatory capacity of interleukin-21 in the pathogenesis of autoimmune disease.

Vogelzang A, King C.

Front Biosci. 2008 May 1;13:5304-15. Review.

PMID:
18508588
5.

Interferons and autoimmune disorders.

Meyer O.

Joint Bone Spine. 2009 Oct;76(5):464-73. doi: 10.1016/j.jbspin.2009.03.012. Epub 2009 Sep 20. Review.

PMID:
19773191
6.

Dendritic cells and interferon-mediated autoimmunity.

Gottenberg JE, Chiocchia G.

Biochimie. 2007 Jun-Jul;89(6-7):856-71. Epub 2007 May 5. Review.

PMID:
17562353
7.

Interferon alpha and its contribution to autoimmunity.

Selmi C, Lleo A, Zuin M, Podda M, Rossaro L, Gershwin ME.

Curr Opin Investig Drugs. 2006 May;7(5):451-6. Review.

PMID:
16729722
8.

Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity.

Kunz M, Ibrahim SM.

Mediators Inflamm. 2009;2009:979258. doi: 10.1155/2009/979258. Epub 2009 Oct 26. Review.

9.

Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments.

Kollias G, Kontoyiannis D.

Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):315-21. Review.

PMID:
12220546
10.

The AKT axis as a therapeutic target in autoimmune diseases.

Wu T, Mohan C.

Endocr Metab Immune Disord Drug Targets. 2009 Jun;9(2):145-50. Review.

PMID:
19519464
11.

Mapping and identification of autoimmunity genes.

Encinas JA, Kuchroo VK.

Curr Opin Immunol. 2000 Dec;12(6):691-7. Review.

PMID:
11102774
12.

Ingested type I interferon: a potential treatment for autoimmunity.

Brod SA.

J Interferon Cytokine Res. 2002 Dec;22(12):1153-66. Review.

PMID:
12581487
13.

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.

Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B.

Arthritis Rheum. 2009 Jun;60(6):1785-96. doi: 10.1002/art.24557.

15.

Immuno- and genetic therapy in autoimmune diseases.

Chernajovsky Y, Dreja H, Daly G, Annenkov A, Gould D, Adams G, Croxford JL, Baker D, Podhajcer OL, Mageed RA.

Genes Immun. 2000 Jun;1(5):295-307. Review.

16.

Natural killer T cells and autoimmune disease.

Wu L, Van Kaer L.

Curr Mol Med. 2009 Feb;9(1):4-14. Review.

PMID:
19199937
17.

At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.

Barnado A, Crofford LJ, Oates JC.

J Leukoc Biol. 2016 Feb;99(2):265-78. doi: 10.1189/jlb.5BT0615-234R. Epub 2015 Dec 11. Review.

PMID:
26658004
18.

Dendritic cells, chemokine receptors and autoimmune inflammatory diseases.

Cravens PD, Lipsky PE.

Immunol Cell Biol. 2002 Oct;80(5):497-505. Review.

PMID:
12225387
19.

Clinically validated approaches to the treatment of autoimmune diseases.

Carter PH, Zhao Q.

Expert Opin Investig Drugs. 2010 Feb;19(2):195-213. doi: 10.1517/13543780903418452. Review.

PMID:
20050823
20.

Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases.

Lee S, Ballow M.

J Allergy Clin Immunol. 2010 Apr;125(4):814-20. doi: 10.1016/j.jaci.2010.02.025. Review.

PMID:
20371395

Supplemental Content

Support Center